Skip to content
Engineering, Medical Health Aged Care

Monash engineers make discovery that gives babies with hearing impairment new hope

Monash University 2 mins read

Monash University Electrical and Computer Systems Engineering and Bionics Institute research teams have used cutting edge light technology invisible to the human eye to non-invasively image brains to help diagnose hearing impairments in infants and prescribe the most effective treatment as early as possible.

Prolonged hearing loss can severely affect how the brain’s language areas develop, affecting a child’s ability to develop speech and language. Currently, several diagnostic tests are required to accurately determine the extent of hearing impairment in infants. Tests can extend for several months and are stressful for both the child and the parents. 

PhD student Ishara Paranawithana and a team of researchers used functional near-infrared spectroscopy (fNIRS) to non-invasively image the brains of a group of normal hearing infants and measure how language areas of their brains develop and interconnect over time as they grow older. The results were published in the Journal of Neural Engineering.

The study analysed the functional connectivity changes that occur in the brains of normal hearing infants to explore how primary language areas typically develop in the first year of life.

Mr Paranawithana said the objective measurements of connectivity from normal hearing infants can be used as potential biomarkers to compare against those of infants with hearing impairment to determine their level of language development.

“Since the age of the infants in our study varied considerably, we could quantify how these regions become increasingly functionally linked together with age and compare with the connectivity levels seen in adults by the end of the first year,” he said.

“By establishing the typical developmental trajectory of language areas in early childhood our results help us to better understand the altered connectivity and its effects on language delays often seen in hearing-impaired infants.  

“Functional near-infrared spectroscopy (fNIRS) is a relatively inexpensive and child-friendly brain imaging technique suitable for clinical use. Having diagnostic tools that facilitate early assessment of hearing helps infants with impaired hearing access effective treatments earlier in life, giving them the best chance to keep up with their peers.” 

These findings will contribute to future expanded capability of a new bionics device developed by the Bionics Institute called EarGenie, which is currently undergoing a clinical trial.

Professor Colette McKay, lead researcher of infant hearing at the Bionics Institute, said this study is critical to understanding how language processing develops in infants.

 

“The findings will help us track development of language in infants with hearing impairment, and optimise and fast track their early intervention,” Professor McKay said.

“Ultimately, we want to give babies born deaf or hard of hearing the best chance of hearing clearly and learning to talk.” 

- ENDS -

 

MEDIA ENQUIRIES

Loretta Wylde

Monash University

Media and Communications

E: [email protected]

T: +61 (0) 432 123 106

GENERAL MEDIA ENQUIRIES

Monash Media

T: +61 (0) 3 9903 4840

E: [email protected]

For more Monash media stories, visit our news and events site 

 

Media

More from this category

  • Medical Health Aged Care
  • 09/03/2026
  • 13:19
Dementia Australia

Dementia Australia supports Central Highlands

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support inthe Central Highlands, Queensland, between17-19March,2026. It is estimated there are almost88,200people living with dementia inQueensland.Without a medical breakthrough this number is expected to increase to more than168,300people living with dementia by 2054.  The Dementia Australia sessions are an opportunity for people living with dementia, theircarers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential.   Understanding Dementia This sessionprovides an introduction todementia including…

  • Medical Health Aged Care
  • 09/03/2026
  • 13:12
Australian Cardiovascular Alliance (ACvA)

Australian Cardiovascular Alliance welcomes National Chronic Conditions Strategic Framework

The Australian Cardiovascular Alliance (ACvA) welcomes the Australian Government’s launch of the National Chronic Conditions Strategic Framework 2026–35, which sets Australia’s long-term plan to prevent and manage chronic illness. Four million Australians, nearly one in seven, are living with heart disease, a leading driver of health spending, costing approximately $16.9 billion in 2023–24. With the framework now in place and a commitment of $109.9 million over three years through the Chronic Conditions Prevention and Integrated Care Program, ACvA looks forward to working with government on tackling the leading cause of burden of disease and improving cardiovascular disease (CVD) prevention and…

  • Medical Health Aged Care
  • 09/03/2026
  • 13:11
Dementia Australia

Dementia Australia supports Broome

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support inBroomebetween23-27March,2026. It is estimated there are almost43,400people living with dementia inWestern Australia.Without a medical breakthrough this number is expected to increase to more than87,000people living with dementia by 2054.  The Dementia Australia sessions are an opportunity for people living with dementia, theircarers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential.   Worried About Your Memory? This session provides information on memory and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.